tyrosine kinase inhibitor BIBF 1120
All > Medicine > Cancer
- (TY-ruh-seen KY-nayz in-HIH-bih-ter...) A substance being studied in the treatment of some types of cancer. Tyrosine kinase inhibitor BIBF 1120 blocks enzymes needed for cells to grow, and may prevent the growth of new blood vessels needed for tumors to grow. It is a type of tyrosine kinase inhibitor. Also called BIBF 1120.
National Cancer Institute - Cite This Source - This Definition - axitinib, AZD0530, AZD2171, BIBF 1120, cediranib, CT53518, MLN518, MP470, Recentin, tandutinib, tyrosine kinase inhibitor, vandetanib, vascular endothelial growth factor receptor tyrosine kinase inhibitor, VEGFR tyrosine kinase inhibitor, XL880, Zactima